Literature DB >> 15174525

Nasopharyngeal carcinoma metastasis to the pituitary gland: a case report and literature review.

G Brandon Gunn1, Ruben D Villa, Ross R Sedler, Fred Hardwicke, Gianluigi A Fornari, Rufus J Mark.   

Abstract

While nasopharyngeal carcinoma (NPC) commonly invades the skull base, true central nervous system metastasis is a rare phenomenon. We report a case of NPC metastasis to the pituitary gland and review the literature for similar events. Eight months after his definitive radiation therapy, our patient presented with symptoms of optic chiasm compression and panhypopituitarism. Medical imaging revealed a pituitary mass but demonstrated no evidence of skull base erosion or direct intracranial extension. Subsequent biopsy of the pituitary lesion was confirmed as NPC in origin with Epstein-Barr virus-encoded RNA in-situ hybridization studies. The patient was treated with high dose chemotherapy followed by autologous stem cell transplant, which produced short-term symptomatic relief and at least a 7 month survival.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15174525     DOI: 10.1023/b:neon.0000024750.93572.ce

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  14 in total

1.  Nasopharyngeal carcinoma with leptomeningeal dissemination: case report.

Authors:  C J Wang; C Y Wang
Journal:  Chang Gung Med J       Date:  2000-02

2.  Expression of EBER1 in primary and metastatic nasopharyngeal carcinoma tissues using in situ hybridization. A correlation with WHO histologic subtypes.

Authors:  S T Tsai; Y T Jin; I J Su
Journal:  Cancer       Date:  1996-01-15       Impact factor: 6.860

3.  Metastatic cancer of the pituitary gland.

Authors:  K Kovacs
Journal:  Oncology       Date:  1973       Impact factor: 2.935

4.  Intramedullary cervical cord metastasis from a nasopharynx carcinoma.

Authors:  M A Morariu; M Serban
Journal:  Eur Neurol       Date:  1974       Impact factor: 1.710

5.  Feasibility and long-term results of autologous PBSC transplantation in recurrent undifferentiated nasopharyngeal carcinoma.

Authors:  M Airoldi; A De Crescenzo; F Pedani; S Marchionatti; A M Gabriele; G Succo; G Rosti; C Bumma
Journal:  Head Neck       Date:  2001-09       Impact factor: 3.147

6.  Epstein-Barr virus early ribonucleic acids as a diagnostic adjunct for relapsed metastatic tumors in patients with cured primary undifferentiated nasopharyngeal carcinoma.

Authors:  C L Ho; S H Lee; L M Chen; T Y Chao
Journal:  Am J Otolaryngol       Date:  2000 Mar-Apr       Impact factor: 1.808

7.  Distant metastases in nasopharyngeal carcinoma.

Authors:  T H Khor; B C Tan; E J Chua; K B Chia
Journal:  Clin Radiol       Date:  1978-01       Impact factor: 2.350

8.  Nasopharyngeal carcinoma with brain metastasis: a case report.

Authors:  C C Liaw; Y S Ho; N G Koon-Kwan; T L Chen; W C Tzann
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

9.  Symptomatic pituitary metastases.

Authors:  A Morita; F B Meyer; E R Laws
Journal:  J Neurosurg       Date:  1998-07       Impact factor: 5.115

10.  Leukemoid reaction, bone marrow invasion, fever of unknown origin, and metastatic pattern in the natural history of advanced undifferentiated carcinoma of nasopharyngeal type: a review of 255 consecutive cases.

Authors:  E Cvitkovic; M Bachouchi; H Boussen; P Busson; G Rousselet; R Mahjoubi; P Flores; T Tursz; J P Armand; N Azli
Journal:  J Clin Oncol       Date:  1993-12       Impact factor: 44.544

View more
  2 in total

Review 1.  Clinical and biochemical characteristic features of metastatic cancer to the sella turcica: an analytical review.

Authors:  Ribal Al-Aridi; Katia El Sibai; Pingfu Fu; Mehreen Khan; Warren R Selman; Baha M Arafah
Journal:  Pituitary       Date:  2014-12       Impact factor: 4.107

2.  Pituitary metastasis: a rare condition.

Authors:  Aida Javanbakht; Massimo D'Apuzzo; Behnam Badie; Behrouz Salehian
Journal:  Endocr Connect       Date:  2018-08-23       Impact factor: 3.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.